Blood Substitutes

Definition : Substances designed to substitute all or some of the properties of human blood or its components. A whole blood substitute should provide a reasonable amount of oxygen delivery when compared with human red blood cells, should be readily available, and have a long storage life, preferably at room temperature; the substitute should not induce immune responses (i.e., lack of antigenicity) and have a low capability to transmit infections. Most blood substitutes are intended to provide a substitute for the oxygen-carrying capabilities of blood (i.e., red blood cell substitutes); there are also some blood component substances intended as platelet substitutes.

UMDC code : 35273

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-2 of 2 Match(es).

Bio/Data Corp

Company Type: Parent

Founded in 1969, Bio/Data Corporation pioneered the use of optical and kinetic clot detection for Coagulation Analyzers and introduced the first automated platelet aggregometer in 1974. We continued to lead the industry by introducing the first dual channel platelet aggregometer and marketing a complete line of aggregation reagents.

Tenax Therapeutics Inc

Company Type: Parent

1-2 of 2 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone